These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 25561809

  • 1. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.
    Wei XL, Wang DS, Xi SY, Wu WJ, Chen DL, Zeng ZL, Wang RY, Huang YX, Jin Y, Wang F, Qiu MZ, Luo HY, Zhang DS, Xu RH.
    World J Gastroenterol; 2014 Dec 28; 20(48):18404-12. PubMed ID: 25561809
    [Abstract] [Full Text] [Related]

  • 2. Various ARID1A expression patterns and their clinical significance in gastric cancers.
    Kim YB, Ham IH, Hur H, Lee D.
    Hum Pathol; 2016 Mar 28; 49():61-70. PubMed ID: 26826411
    [Abstract] [Full Text] [Related]

  • 3. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
    Lee LH, Sadot E, Ivelja S, Vakiani E, Hechtman JF, Sevinsky CJ, Klimstra DS, Ginty F, Shia J.
    Hum Pathol; 2016 Jul 28; 53():97-104. PubMed ID: 26980037
    [Abstract] [Full Text] [Related]

  • 4. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
    Kozak MM, von Eyben R, Pai J, Vossler SR, Limaye M, Jayachandran P, Anderson EM, Shaffer JL, Longacre T, Pai RK, Koong AC, Chang DT.
    J Clin Pathol; 2015 May 28; 68(5):341-5. PubMed ID: 25681512
    [Abstract] [Full Text] [Related]

  • 5. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH, Lee C, Suh JH, Chae JY, Kim HW, Moon KC.
    Hum Pathol; 2015 Mar 28; 46(3):454-60. PubMed ID: 25628030
    [Abstract] [Full Text] [Related]

  • 6. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
    Formentini A, Henne-Bruns D, Kornmann M.
    Hepatogastroenterology; 2012 Sep 28; 59(118):1859-64. PubMed ID: 22819905
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J, Chen QC, Jin F, Wu HZ, He M, Zhao L, Yu ZJ, Yao WF, Mi XY, Wang EH, Wei MJ.
    Int J Clin Exp Pathol; 2014 Sep 28; 7(9):5595-608. PubMed ID: 25337201
    [Abstract] [Full Text] [Related]

  • 8. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
    Song M, Kim H, Kim WK, Hong SP, Lee C, Kim H.
    Ann Surg Oncol; 2014 Dec 28; 21 Suppl 4():S481-9. PubMed ID: 24366420
    [Abstract] [Full Text] [Related]

  • 9. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.
    J Clin Gastroenterol; 2009 Oct 28; 43(9):831-7. PubMed ID: 19461527
    [Abstract] [Full Text] [Related]

  • 10. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea.
    Kim KH, Yang SS, Yoon YS, Lim SB, Yu CS, Kim JC.
    Colorectal Dis; 2011 Aug 28; 13(8):e220-6. PubMed ID: 21689314
    [Abstract] [Full Text] [Related]

  • 11. COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis.
    Liu F, Ye P, Bi T, Teng L, Xiang C, Wang H, Li Y, Jin K, Mou X.
    Hepatogastroenterology; 2014 May 28; 61(131):652-9. PubMed ID: 26176052
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of integrin αv correlates with poor prognosis in colorectal cancer.
    Ha SY, Shin J, Kim JH, Kang MS, Yoo HY, Kim HH, Um SH, Kim SH.
    J Clin Pathol; 2014 Jul 28; 67(7):576-81. PubMed ID: 24695839
    [Abstract] [Full Text] [Related]

  • 13. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
    Villatoro TM, Ma C, Pai RK.
    Hum Pathol; 2020 May 28; 99():53-61. PubMed ID: 32222462
    [Abstract] [Full Text] [Related]

  • 14. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P, Xu B, Zhang D, Shao Y, Zheng X, Li X, Xiong Y, Wu C, Jiang J.
    Oncotarget; 2017 Jan 03; 8(1):954-966. PubMed ID: 27888614
    [Abstract] [Full Text] [Related]

  • 15. Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma.
    Abe H, Hayashi A, Kunita A, Sakamoto Y, Hasegawa K, Shibahara J, Kokudo N, Fukayama M.
    Int J Clin Exp Pathol; 2015 Jan 03; 8(3):2763-70. PubMed ID: 26045782
    [Abstract] [Full Text] [Related]

  • 16. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW, Remzi FH.
    J Am Coll Surg; 2011 Nov 03; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [Abstract] [Full Text] [Related]

  • 17. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS, Jing CQ, Shan KS, Chen YZ, Guo XB, Cao ZX, Mu LJ, Peng LP, Zhou ML, Li LP.
    World J Gastroenterol; 2015 Feb 21; 21(7):2191-8. PubMed ID: 25717256
    [Abstract] [Full Text] [Related]

  • 18. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
    Bae JM, Lee TH, Cho NY, Kim TY, Kang GH.
    World J Gastroenterol; 2015 Feb 07; 21(5):1457-67. PubMed ID: 25663765
    [Abstract] [Full Text] [Related]

  • 19. The DCC protein and prognosis in colorectal cancer.
    Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele G, Jessup JM, Loda M, Summerhayes IC.
    N Engl J Med; 1996 Dec 05; 335(23):1727-32. PubMed ID: 8929264
    [Abstract] [Full Text] [Related]

  • 20. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.
    Clin Cancer Res; 2008 Jan 01; 14(1):143-8. PubMed ID: 18172264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.